Scotiabank Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $3
Biodesix (BDSX) Receives a Buy From Scotiabank
Biodesix: Strong Growth Prospects Amidst Challenges Lead to Buy Rating
Biodesix, Inc. (NASDAQ:BDSX) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless
TD Cowen Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $3
Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript Summary
Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript
Biodesix Stockholders to Sell 62.2 Million Shares; Files $250 Million Mixed-Shelf Offering
Express News | Biodesix Shares up 5.3% Premarket After Q3 Results
Express News | Biodesix Inc - Files for Mixed Shelf of $250 Mln- SEC Filing
Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates
Biodesix | 10-Q: Q3 2024 Earnings Report
Biodesix GAAP EPS of -$0.07 Beats by $0.01, Revenue of $18.2M Misses by $0.32M
Express News | Biodesix Inc Q3 Shr View $-0.07 -- LSEG IBES Data
Biodesix Backs 2024 Rev $70M-$72M >BDSX
Biodesix 3Q Loss/Shr 7c >BDSX
Earnings Flash (BDSX) BIODESIX Posts Q3 Revenue $18.2M
Express News | Biodesix Q3 Revenue USD 18.2 Million Vs. IBES Estimate USD 18.6 Million
With 47% Ownership, Biodesix, Inc. (NASDAQ:BDSX) Insiders Have a Lot Riding on the Company's Future
Biodesix to Participate in Three Investor Conferences in November